These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4144099)

  • 1. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of two new beta-blocking drugs on heart rate and blood pressure during passive tilting in man.
    Fuccella LM; Reban J; Bassini F; Lattes E; Mandelli V
    Eur J Clin Pharmacol; 1971 Dec; 4(1):12-7. PubMed ID: 4402874
    [No Abstract]   [Full Text] [Related]  

  • 4. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of -adrenoceptor antagonists on the decline of the chronotropic response to isoprenaline.
    Fenyvesi T; George CF; Dollery CT
    J Pharm Pharmacol; 1972 Apr; 24(4):313-7. PubMed ID: 4402839
    [No Abstract]   [Full Text] [Related]  

  • 8. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
    Marmo E; Saini RK; Caputi AP
    Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A).
    Lewis BS; Bakst A; Mitha AS; Purdon K; Gotsman MS
    Br Heart J; 1973 Jul; 35(7):743-51. PubMed ID: 4146280
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of ICI 50,172 on cardio-respiratory parameters in dogs].
    Tavares P; Viana AR; Ximenes-Neto M; Martinelli JG
    Rev Bras Anestesiol; 1971; 21(4):596-601. PubMed ID: 4401689
    [No Abstract]   [Full Text] [Related]  

  • 12. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological aspects of oxprenolol.
    Brunner H; Hedwall PR; Maier R; Meier M
    Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
    Cheymol G; Honnorat C; Schmitt H
    Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic studies on the beta receptor blockader Kö 592 under rest and under exertion].
    Deibert K; Steim H; Heinrich K; Siller K
    Med Klin; 1972 Jun; 67(24):845-9. PubMed ID: 4403610
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of 1-(isopropylamino)-3-(m-toyloxy)-2-propanol hydrochloride (Doberol) on the bronchial system after oral administration].
    Günthner W
    Eur J Clin Pharmacol; 1972 Jun; 4(3):185-90. PubMed ID: 4144065
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade.
    Prys-Roberts C; Foëx P; Biro GP; Roberts JG
    Br J Anaesth; 1973 Jul; 45(7):671-81. PubMed ID: 4147153
    [No Abstract]   [Full Text] [Related]  

  • 19. [Optical antipodes of adrenergic beta receptor blocking agent 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanol].
    Meier M; Hedwall PR; Imhof P; Wilhelm M; Brunner H
    Arzneimittelforschung; 1970 Dec; 20(12):1890-6. PubMed ID: 4395650
    [No Abstract]   [Full Text] [Related]  

  • 20. General and coronary haemodynamic effects of 1-(O-allyloxphenoxy)-3-isopropylamino-2-propanol hydrochloride.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1968 May; 173(1):226-31. PubMed ID: 5657822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.